164 related articles for article (PubMed ID: 10732792)
1. The role of cytokines in both the normal and malignant ovary.
Nash MA; Ferrandina G; Gordinier M; Loercher A; Freedman RS
Endocr Relat Cancer; 1999 Mar; 6(1):93-107. PubMed ID: 10732792
[TBL] [Abstract][Full Text] [Related]
2. Tumor-stromal cytokine interactions in ovarian neoplasms.
Kacinski BM
EXS; 1995; 74():181-90. PubMed ID: 8527894
[No Abstract] [Full Text] [Related]
3. Characteristic cytokine generation patterns in cancer cells and infiltrating lymphocytes in oral squamous cell carcinomas and the influence of chemoradiation combined with immunotherapy on these patterns.
Yamamoto T; Kimura T; Ueta E; Tatemoto Y; Osaki T
Oncology; 2003; 64(4):407-15. PubMed ID: 12759539
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous T cell lymphoma reactive CD4+ cytotoxic T lymphocyte clones display a Th1 cytokine profile and use a fas-independent pathway for specific tumor cell lysis.
Echchakir H; Bagot M; Dorothée G; Martinvalet D; Le Gouvello S; Boumsell L; Chouaib S; Bensussan A; Mami-Chouaib F
J Invest Dermatol; 2000 Jul; 115(1):74-80. PubMed ID: 10886511
[TBL] [Abstract][Full Text] [Related]
5. Tumor-host interaction: analysis of cytokines, growth factors, and tumor-infiltrating lymphocytes in ovarian carcinomas.
Merogi AJ; Marrogi AJ; Ramesh R; Robinson WR; Fermin CD; Freeman SM
Hum Pathol; 1997 Mar; 28(3):321-31. PubMed ID: 9042797
[TBL] [Abstract][Full Text] [Related]
6. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
[TBL] [Abstract][Full Text] [Related]
7. Minireview: Regulatory T Cells and Ovarian Cancer.
Singh M; Loftus T; Webb E; Benencia F
Immunol Invest; 2016 Nov; 45(8):712-720. PubMed ID: 27420920
[TBL] [Abstract][Full Text] [Related]
8. Selective expression of interleukin 10, interferon gamma, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies.
Pisa P; Halapi E; Pisa EK; Gerdin E; Hising C; Bucht A; Gerdin B; Kiessling R
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7708-12. PubMed ID: 1502188
[TBL] [Abstract][Full Text] [Related]
9. Immunopathogenesis of ovarian cancer.
Thompson MS; Mok SC
Minerva Med; 2009 Oct; 100(5):357-70. PubMed ID: 19910889
[TBL] [Abstract][Full Text] [Related]
10. Connective tissue activation. XXXVII. Effects of cytokine combinations, implications for an integrated cytokine network.
Castor CW; Smith EM; Bignall MC; Hossler PA
J Rheumatol; 1997 Nov; 24(11):2080-9. PubMed ID: 9375864
[TBL] [Abstract][Full Text] [Related]
11. Both IL-2 and IL-4 synergize with IL-12 to induce a CTL response, a response completely blocked by TGF-beta.
Herrmann S; Abdi K
Ann N Y Acad Sci; 1996 Oct; 795():168-80. PubMed ID: 8958927
[No Abstract] [Full Text] [Related]
12. Cytokine production profiles in the peritoneal fluids of patients with malignant or benign gynecologic tumors.
Punnonen R; Teisala K; Kuoppala T; Bennett B; Punnonen J
Cancer; 1998 Aug; 83(4):788-96. PubMed ID: 9708947
[TBL] [Abstract][Full Text] [Related]
13. Secretion of bioactive interleukin-1, interleukin-6, and colony-stimulating factors by human ovarian surface epithelium.
Ziltener HJ; Maines-Bandiera S; Schrader JW; Auersperg N
Biol Reprod; 1993 Sep; 49(3):635-41. PubMed ID: 7691194
[TBL] [Abstract][Full Text] [Related]
14. Oocyte-somatic cell interactions in the human ovary-novel role of bone morphogenetic proteins and growth differentiation factors.
Chang HM; Qiao J; Leung PC
Hum Reprod Update; 2016 Dec; 23(1):1-18. PubMed ID: 27797914
[TBL] [Abstract][Full Text] [Related]
15. Cytokine-based transformation of immune surveillance into tumor-promoting inflammation.
Mumm JB; Oft M
Oncogene; 2008 Oct; 27(45):5913-9. PubMed ID: 18836472
[TBL] [Abstract][Full Text] [Related]
16. Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.
Bellone S; Anfossi S; O'Brien TJ; Cannon MJ; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
Cancer; 2009 Feb; 115(4):800-11. PubMed ID: 19117353
[TBL] [Abstract][Full Text] [Related]
17. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
[TBL] [Abstract][Full Text] [Related]
18. The comparison of cytotoxic T-lymphocyte effects of dendritic cells stimulated by the folate binding protein peptide cultured with IL-15 and IL-2 in solid tumor.
Kim DK; Kim JH; Kim YT; Kim JW; Ioannides CG
Yonsei Med J; 2002 Dec; 43(6):691-700. PubMed ID: 12497651
[TBL] [Abstract][Full Text] [Related]
19. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP
Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180
[TBL] [Abstract][Full Text] [Related]
20. The importance of neuronal growth factors in the ovary.
Streiter S; Fisch B; Sabbah B; Ao A; Abir R
Mol Hum Reprod; 2016 Jan; 22(1):3-17. PubMed ID: 26487421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
